Patents by Inventor M. Patricia Beckmann

M. Patricia Beckmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Elk ligand fusion proteins
    Patent number: 5670625
    Abstract: elk ligand (elk-L) polypeptides as well as DNA sequences, vectors and transformed host cells useful in providing elk-L polypeptides. The elk-L polypeptide binds to a cell surface receptor that is a member of the tyrosine kinase receptor family.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: September 23, 1997
    Assignee: Immunex Corporation
    Inventors: Stewart Lyman, M. Patricia Beckmann, Peter R. Baum
  • Cytokine designated elk ligand
    Patent number: 5627267
    Abstract: elk ligand (elk-L) polypeptides as well as DNA sequences, vectors and transformed host cells useful in providing elk-L polypeptides. The elk-L polypeptide binds to a cell surface receptor that is a member of the tyrosine kinase receptor family.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: May 6, 1997
    Assignee: Immunex Corporation
    Inventors: Stewart Lyman, M. Patricia Beckmann, Peter R. Baum
  • Interleukin-4 receptors
    Patent number: 5599905
    Abstract: Mammalian Interleukin-4 receptor proteins, DNAs and expression vectors encoding mammalian IL-4 receptors, and processes for producing mammalian IL-4 receptors as products of cell culture, are disclosed. A method for suppressing an IL-4-dependent immune or inflammatory response in a mammal, including a human, by administering an effective amount of soluble IL-4 receptor (sIL-4R) and a suitable diluent or carrier.
    Type: Grant
    Filed: July 20, 1993
    Date of Patent: February 4, 1997
    Assignee: Immunex Corporation
    Inventors: Bruce Mosley, David J. Cosman, Linda Park, M. Patricia Beckmann, Carl J. March, Rejean Idzerda
  • CD27 ligand
    Patent number: 5573924
    Abstract: CD27 ligand (CD27L) polypeptide and DNA sequences, vectors and transformed host cells useful in providing CD27L polypeptides. The CD27L polypeptide binds to the CD27 receptor.
    Type: Grant
    Filed: August 13, 1993
    Date of Patent: November 12, 1996
    Assignee: Immunex Corporation
    Inventors: M. Patricia Beckmann, Raymond G. Goodwin, Judith G. Giri, Richard J. Armitage
  • Ligands for flt3 receptors
    Patent number: 5554512
    Abstract: Ligands for flt3 receptors capable of transducing self-renewal signals to regulate the growth, proliferation or differentiation of progenitor cells and stem cells are disclosed. The invention is directed to flt3-L as an isolated protein, the DNA encoding the flt3-L, host cells transfected with cDNAs encoding flt3-L, compositions comprising flt3-L, methods of improving gene transfer to a mammal using flt3-L, and methods of improving transplantations using flt3-L. Flt3-L finds use in treating patients with anemia, AIDS and various cancers.
    Type: Grant
    Filed: May 11, 1994
    Date of Patent: September 10, 1996
    Assignee: Immunex Corporation
    Inventors: Stewart D. Lyman, M. Patricia Beckmann
  • DNA encoding cytokines that bind the cell surface receptor hek
    Patent number: 5516658
    Abstract: Hek ligand (hek-L) polypeptides as well as DNA sequences, vectors and transformed host cells useful in providing hek-L polypeptides. The hek-L polypeptides bind to a cell surface receptor (hek) that is a member of the receptor tyrosine kinase family. Hek is expressed on cells that include certain tumor cell lines. The hek-L polypeptides also bind a distinct receptor tyrosine kinase known elk.
    Type: Grant
    Filed: May 9, 1994
    Date of Patent: May 14, 1996
    Assignee: Immunex Corporation
    Inventors: M. Patricia Beckmann, Douglas P. Cerretti
  • Cytokine designated elk ligand
    Patent number: 5512457
    Abstract: elk ligand (elk-L) polypeptides as well as DNA sequences, vectors and transformed host cells useful in providing elk-L polypeptides. The elk-L polypeptide binds to a cell surface receptor that is a member of the tyrosine kinase receptor family.
    Type: Grant
    Filed: March 15, 1994
    Date of Patent: April 30, 1996
    Assignee: Immunex Corporation
    Inventors: Stewart Lyman, M. Patricia Beckmann, Peter R. Baum, Melissa K. Carpenter
  • DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors
    Patent number: 5395760
    Abstract: Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed.
    Type: Grant
    Filed: May 10, 1990
    Date of Patent: March 7, 1995
    Assignee: Immunex Corporation
    Inventors: Craig A. Smith, Raymond G. Goodwin, M. Patricia Beckmann
  • DNA encoding leukemia inhibitory factor receptors
    Patent number: 5284755
    Abstract: Leukemia inhibitory factor receptor (LIF-R) proteins, DNAs and expression vectors encoding LIF-R, and processes for producing LIF-R as products of recombinant cell culture, are disclosed.
    Type: Grant
    Filed: September 11, 1992
    Date of Patent: February 8, 1994
    Assignee: Immunex Corporation
    Inventors: David P. Gearing, M. Patricia Beckmann